When sponsored CDS is a crime …
Today, The Department of Justice issued an announcement that was “the first ever criminal action against an EHR vendor.”
Criminal action
The core of the criminal action was something inevitable: the tension between better health and better profit. Here’s what I saw … all of which caused me to be not-so-surprised today when the news broke.
In 2008 I was the CMIO at Allscripts. Much of my work was focused on how our customers could use our products to improve the health of our patients. We implemented clinical practice guidelines in the software as a way to help clinical teams and patients mak...
Source: Docnotes - January 28, 2020 Category: Primary Care Authors: Jacob Tags: Uncategorized Source Type: blogs
Will Medicare Advantage (MA) Startup Plans Be The Future?
By ANDY MYCHKOVSKY
Would it blow your mind if only five startup health plans interested in Medicare Advantage (MA) have collectively raised over $3.9 billion in private funding to-date? Well, readers, that is the reality. Now I know there are some skeptics out in the healthcare ecosystem, so I’m here to break down some of the investment thesis. Not going to necessarily defend, but explain some reasons why you should love and hate these investments. Let’s start with who raised these mind-boggling sums of money. The five startups are Oscar Health, Bright Health, Clover Health, Devoted Health, and Alignment Healthcare....
Source: The Health Care Blog - January 23, 2020 Category: Consumer Health News Authors: Christina Liu Tags: Health Policy Medicare Alignment Healthcare Andy Mychkovsky Bright Health Clover Health devoted health Healthcare Pizza Medicare Advantage Oscar Oscar Health Source Type: blogs
9 Healthcare Companies Who Changed the 2010s
By ANDY MYCHKOVSKY
In order to celebrate the next decade (although the internet is confused whether its actually the end of the decade…), we’re taking a step back and listing our picks for the 9 most influential healthcare companies of the 2010s. If your company is left off, there’s always next decade… But honestly, we tried our best to compile a unique listing that spanned the gamut of redefining healthcare for a variety of good and bad reasons. Bon appétit!
1. Epic Systems Corporation
The center of the U.S. electronic medical record (EMR) universe resides in Verona, Wisconsin. Population of 13,166. The ...
Source: The Health Care Blog - January 7, 2020 Category: Consumer Health News Authors: Christina Liu Tags: Health Tech Health Technology Start-Ups Andy Mychkovsky Healthcare Pizza Innovation Startups Source Type: blogs
The Lynne Chou O ’ Keefe Fallacy
By MATTHEW HOLT
Rob Coppedge and Bryony Winn wrote an interesting article in Xconomy yesterday. I told Rob (& the world) on Twitter yesterday that it was good but wrong. Why was it wrong? Well it encompasses something I’m going to call the Lynne Chou O’Keefe Fallacy. And yes, I’ll get to that in a minute. But first. What did Rob and Bryony say?
Having walked the halls and corridors and been deafened by the DJs at HLTH, Rob & Bryony determined why many digital health companies have failed (or will fail) and a few have succeeded. They’ve dubbed the winners “Digital Health Survivors...
Source: The Health Care Blog - December 4, 2019 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Health Tech The Business of Health Care BCBS of North Carolina Cambia Health Solutions Define ventures Echo Health Ventures Matthew Holt Source Type: blogs
The AMA and ABMS Member Boards: Banking on the Promise of Private Equity
Recently, I was sent a prospectus for a medical device company that caught the eye of a local Venture Capital funding group. On that prospectus was this paragraph for a "vision" of future of a "clinical decision support system:"Collects data from the electronic medical record, medical literature, regulatory warnings and other internet-based public information. Provides analysis of (Source: Dr. Wes)
Source: Dr. Wes - November 24, 2019 Category: Cardiology Authors: Westby G. Fisher, MD Source Type: blogs
---
In their essay for Harvard Business Review, the Commonwealth Fund’s Lovisa Gustafsson, Shanoor Seervai, and David Blumenthal, M.D., argue that private equity and venture capital firms that invest in health care will benefit most if they add true value to our health system.
(Source: The Commonwealth Fund: Blog)
Source: The Commonwealth Fund: Blog - November 22, 2019 Category: International Medicine & Public Health Authors: Lovisa Gustafsson, Shanoor Seervai, David Blumenthal, M.D. Source Type: blogs
Fight Aging! Newsletter, November 11th 2019
In conclusion, high-dose NR induces the onset of WAT dysfunction, which may in part explain the deterioration of metabolic health.
Towards a Rigorous Definition of Cellular Senescence
https://www.fightaging.org/archives/2019/11/towards-a-rigorous-definition-of-cellular-senescence/
The accumulation of lingering senescent cells is a significant cause of aging, disrupting tissue function and generating chronic inflammation throughout the body. Even while the first senolytic drugs capable of selectively destroying these cells already exist, and while a number of biotech companies are working on the producti...
Source: Fight Aging! - November 10, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Support Rejuvenation Research by Donating to the SENS Research Foundation Winter 2019 Fundraiser
Winter is upon us, and thus the yearly winter SENS Research Foundation fundraiser just recently started a few days ago. For those who don't know, the SENS Research Foundation remains one of the most important and influential organizations working on advancing rejuvenation research to the point at which it can be moved into clinical development and funded by venture capital. Through conferences and advocacy, the SENS Research Foundation staff also played a sizable role in ensuring that there is in fact an active venture capital community eager to back new companies working on the treatment of aging.
All of this w...
Source: Fight Aging! - November 4, 2019 Category: Research Authors: Reason Tags: Activism, Advocacy and Education Source Type: blogs
Fight Aging! Newsletter, November 4th 2019
In this study, we hypothesized that moderately and chronically reducing ACh could attenuate the deleterious effects of aging on NMJs and skeletal muscles. To test this hypothesis, we analyzed NMJs and muscle fibers from heterozygous transgenic mice with reduced expression of the vesicular ACh transporter (VAChT), VKDHet mice, which present with approximately 30% less synaptic ACh compared to control mice.
Because ACh is constitutively decreased in VKDHet, we first analyzed developing NMJs and muscle fibers. We found no obvious morphological or molecular differences between NMJs and muscle fibers of VKDHet and contro...
Source: Fight Aging! - November 3, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
A Perspective on Longevity Biotech Investment from James Peyer of Kronos BioVentures
James Peyer, formerly of Apollo Ventures and now at the larger Kronos BioVentures, has a range of interesting views on the new and growing longevity biotechnology industry. Apollo Ventures was one of the earlier longevity-focused funds to emerge from the comparatively small community of scientists, patient advocates, and investors enthusiastic to accelerate progress towards the treatment of aging as a medical condition. The presentation here was given earlier this year at the Ending Age-Related Diseases conference organized by the Life Extension Advocacy Foundation.
In the matter of creating new medical therapies, t...
Source: Fight Aging! - October 30, 2019 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
Q & A: What does the Facebook acquisition of CTRL-Labs mean for Neurotechnology and Augmented & Virtual Reality?
__________
While sitting at dinner with an unsuspecting friend, my phone blew up with oddly-late messages from fellow neurotechnology comrades. CTRL-Labs announced their impending acquisition by Facebook and integration into Facebook Reality Labs (responsible for Oculus et al.), for enough money to buy my guilt-inducingly-expensive New York coffee for a meager 550,000 years. Woah—so very many questions. I figured I’d share (and consider this an open invitation to reach out and throw in your 100 billion cents-worth).
As a quick note before proceeding, aside from its pragmatic communication implications, I...
Source: SharpBrains - September 26, 2019 Category: Neuroscience Authors: Avery Bedows Tags: Cognitive Neuroscience Technology AR/VR central nervous system cognition Consumer neurotechnology Ctrl-labs EMG emotion Facebook Facebook Reality Labs medical neurotechnolog Source Type: blogs
The infiltration of venture capital and private equity in the surprise medical bills debate
As proposals to ban surprise medical bills move through Congress and state legislatures with rare bipartisan support, physician groups have emerged as the loudest opponents. Often led by doctors with the veneer of noble concern for patients, physician-staffing firms — third-party companies that employ doctors and assign them out to health care facilities — have […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - September 17, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/rachel-bluth-and-emmarie-huetteman" rel="tag" > Rachel Bluth and Emmarie Huetteman < /a > < /span > Tags: Policy Public Health & Source Type: blogs
Spurring Investment in Type 1 Diabetes: A Look at JDRF's T1D Fund
Diabetes advocacy org JDRF has created a venture capital fund to spur investment in new medtech-based treatments for type 1 diabetes. (Source: Diabetes Mine)
Source: Diabetes Mine - August 26, 2019 Category: Endocrinology Authors: Mike Hoskins Source Type: blogs
Support for LIfT Biosciences to Develop the LIFT Approach to a Universal Cancer Therapy
It is good to see that more of the promising technical approaches to aspects of aging, originally put forward by people in the SENS rejuvenation research network some years ago, are now making solid progress towards commercial implementation. The LIFT, or GIFT, approach to cancer therapy involves the transplantation of suitably aggressive leukocyte or granulocyte immune cells from a donor. At the time it was first demonstrated to be highly effective in mice, more than a decade ago, the underlying mechanisms were not well explored, and that always makes it hard to obtain further support from scientific funding institutions....
Source: Fight Aging! - August 15, 2019 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
